Direct utility of natural history data in analysis of clinical trials: Propensity match-based analysis of Omaveloxolone in Friedreich ataxia using the FA-COMS dataset

David R Lynch, Angie Goldsberry, Christian Rummey, Jennifer Farmer, Sylvia Boesch, Martin B. Delatycki, Paola Giunti, J. Chad Hoyle, Caterina Mariotti, Katherine D. Mathews, Wolfgang Nachbauer, Susan Perlman, S.H. Subramony, George Wilmot, Theresa Zesiewicz, Lisa Weissfeld, Colin Meyer
doi: https://doi.org/10.1101/2022.08.12.22278684

Data Availability

All files from FACOMS data are held in a public repository at cPATH. (https://c-path.org/programs/rdca-dap/working-group/fa-icd/). Data from the MOXIe extension will not be available.

https://c-path.org/programs/dcc/projects/friedreichs-ataxia/

Back to top
Posted August 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Direct utility of natural history data in analysis of clinical trials: Propensity match-based analysis of Omaveloxolone in Friedreich ataxia using the FA-COMS dataset
David R Lynch, Angie Goldsberry, Christian Rummey, Jennifer Farmer, Sylvia Boesch, Martin B. Delatycki, Paola Giunti, J. Chad Hoyle, Caterina Mariotti, Katherine D. Mathews, Wolfgang Nachbauer, Susan Perlman, S.H. Subramony, George Wilmot, Theresa Zesiewicz, Lisa Weissfeld, Colin Meyer
medRxiv 2022.08.12.22278684; doi: https://doi.org/10.1101/2022.08.12.22278684
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area